Lanifibranor

  • CAT Number: I007614
  • CAS Number: 927961-18-0
  • Molecular Formula: C19H15ClN2O4S2
  • Molecular Weight: 434.909
  • Purity: ≥95%
Inquiry Now

Lanifibranor(CAT: I007614) is a pharmaceutical compound also referred to as IVA-337. Functioning as a peroxisome proliferator-activated receptor (PPAR) agonist, Lanifibranor modulates the activity of these nuclear receptors involved in various biological processes, including metabolism and inflammation. By activating PPARs, Lanifibranor may contribute to the regulation of gene expression and metabolic pathways, potentially offering therapeutic benefits in conditions such as metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), and other disorders with underlying inflammation and metabolic disturbances.

Catalog Number I007614
CAS Number 927961-18-0
Molecular Formula

C19H15ClN2O4S2

Purity 95%
Target PARP agonist
Solubility Soluble in DMSO
Storage 0 - 4°C for short term , or -20°C for long term.
SMILES O=C(O)CCCC(N1S(=O)(C2=CC=C3N=CSC3=C2)=O)=CC4=C1C=CC(Cl)=C4
Reference

</br>1:Bruni C, Praino E, Allanore Y, Distler O, Gabrielli A, Iannone F, Matucci-Cerinic M. Use of biologics and other novel therapies for the treatment of systemic sclerosis. Expert Rev Clin Immunol. 2016 Dec 12:1-14. [Epub ahead of print] PubMed PMID: 27899043.

Request a Quote

Contact Us at MuseChem

We are committed to providing you with reliable, cost-effective solutions for your chemical needs, while ensuring your safety and comfort. Our team of experts is always available to answer your questions and help you navigate the complexities of the chemical industry.

Whether you're looking for a specific product or need help with a custom synthesis project, we're here to help you discover a new world of chemical possibilities. Contact us today to learn more about how we can assist you with all of your chemical needs.

Our goal is to make the process of ordering chemicals as seamless and hassle-free as possible. Let us know how we can assist you, and we'll get back to you as soon as possible. We look forward to hearing from you!